Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject has signed informed consent;
Current DSM-IV-TR diagnosis of schizophrenia;
Clinically stable on the same single second-generation antipsychotic for the past 8 weeks;
Meets study-specific PANSS criteria;
Willing and able to cooperate with cognitive testing
Females are not pregnant, not breast-feeding;
Females are post-menopausal or surgically sterile or practicing birth control;
Males are surgically sterile or agree to be sexually inactive or use barrier method of birth control
You may not be if
Subject has a substance dependence disorder that has not been in sustained remission for at least 1 year;
Diagnosis of schizoaffective disorder;
Bipolar disorder, manic episode, dementia, OCD, or drug-induced psychosis or current major depressive disorder;
Diagnoses with mental retardation; acute psychosis hospitalization within past 6 months;
Current clozapine treatment; suicidal ideation or behavior;
BMI of 39 or greater; current homicidal or violent ideation;
Medical or CNS condition other than schizophrenia that could affect cognitive performance or testing; relevant drug sensitivity or allergy; positive urine screen for alcohol or drugs of abuse;
Positive hepatitis or HIV test result;
Recent clinically significant illness/infection or surgery;
Recent blood product transfusion, donation or loss of 5 mL/kg of blood;
